Identifying the patient journey and treatment lines patterns in metastatic pancreatic cancer

Data from patients using the Belong PPN was able to provide insights into the treatment journeys of MPC patients in Israel, the four firstline treatment prevalence and the following lines of treatment. Continuous evaluation of RWE and PRO from the Belong PPN would allow comparative effectiveness research of cancer treatments and lead to improved evidence-based care and patients’ QOL.

Click here to download a PDF version of this study.